Relations of Budd-Chiari syndrome to prothrombin gene mutation

Guo-Ling Lin1, Pei-Qin Xu, Hua Qi

  • 1Department of General Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.

Insights

This study found no prothrombin gene mutation (FII G20210A) in Chinese Budd-Chiari syndrome (BCS) patients. Further research is needed to understand the causes of BCS in this population.

Area of Science:

  • Hepatology
  • Genetics
  • Vascular Medicine

Background:

  • Budd-Chiari syndrome (BCS) involves hepatic vein or inferior vena cava obstruction, leading to portal hypertension.
  • The etiology of BCS is complex, with potential genetic links.
  • Investigating gene mutations is crucial for understanding BCS pathogenesis.

Purpose of the Study:

  • To determine if the prothrombin gene mutation (FII G20210A) is associated with Budd-Chiari syndrome in Chinese patients.
  • To explore the correlativity between FII G20210A mutation and BCS occurrence.

Main Methods:

  • Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was employed.
  • Genome DNA was purified from whole blood samples of 38 BCS patients and 70 controls.
  • DNA fragments were amplified, digested, and analyzed using polyacrylamide gel electrophoresis.

Main Results:

  • The FII G20210A mutation was not detected in any of the studied BCS patients or control subjects.
  • No evidence of a link between FII G20210A mutation and BCS was found.

Conclusions:

  • The FII G20210A mutation is not present in Chinese patients diagnosed with BCS.
  • There is no correlativity between the occurrence of BCS and the FII G20210A mutation in the Chinese population.
  • The underlying causes of BCS in Chinese individuals require further investigation.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pedigree Analysis01:35

Pedigree Analysis

Overview
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Genetic Lingo01:11

Genetic Lingo

Overview
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...